Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 14.03% is 59% above its 5-year average of 8.83%, near the high end of its 5-year range (4.40%–14.03%).
As of the fiscal period ended Wednesday, December 31, 2025. 27.08% above its 12-month average of 11.04%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
14.03%
RETURN ON ASSETS (ROA) AVG TTM
11.04%
RETURN ON ASSETS (ROA) AVG 3Y
9.26%
RETURN ON ASSETS (ROA) AVG 5Y
8.83%
RETURN ON ASSETS (ROA) AVG 10Y
0.82%
RETURN ON ASSETS (ROA) AVG 15Y
-7.74%
RETURN ON ASSETS (ROA) AVG 20Y
-29.13%
CURRENT VS TTM AVG
+27.08%
CURRENT VS 3Y AVG
+51.47%
CURRENT VS 5Y AVG
+58.98%
CURRENT VS 10Y AVG
+1620.51%
CURRENT VS 15Y AVG
+281.34%
CURRENT VS 20Y AVG
+148.16%
SECTOR MEDIAN · HEALTHCARE
4.93%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+184.58%
vs the sector median at left
DexCom, Inc.
Market Cap
$28.31B
Return on Assets (ROA)
14.03%
TTM Avg
11.04%
3Y Avg
9.26%
5Y Avg
8.83%
Market Cap
$27.80B
Return on Assets (ROA)
4.05%
TTM Avg
5.83%
3Y Avg
5.87%
5Y Avg
14.86%
Market Cap
$29.47B
Return on Assets (ROA)
17.30%
TTM Avg
16.00%
3Y Avg
15.15%
5Y Avg
14.03%
Market Cap
$29.55B
Return on Assets (ROA)
4.65%
TTM Avg
5.11%
3Y Avg
6.74%
5Y Avg
8.29%
Market Cap
$27.03B
Return on Assets (ROA)
23.85%
TTM Avg
25.02%
3Y Avg
24.63%
5Y Avg
23.85%
Market Cap
$25.57B
Return on Assets (ROA)
8.21%
TTM Avg
5.75%
3Y Avg
6.24%
5Y Avg
8.30%
Market Cap
$31.61B
Return on Assets (ROA)
-7.94%
TTM Avg
-2.29%
3Y Avg
0.04%
5Y Avg
0.75%
Market Cap
$24.70B
Return on Assets (ROA)
4.93%
TTM Avg
4.41%
3Y Avg
4.42%
5Y Avg
6.18%
Market Cap
$32.24B
Return on Assets (ROA)
17.44%
TTM Avg
17.37%
3Y Avg
16.33%
5Y Avg
15.33%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DexCom, Inc. (DXCM) | $28.31B | 14.03% | 11.04% | 9.26% | 8.83% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $27.80B | 4.05% | 5.83% | 5.87% | 14.86% |
| ResMed Inc. (RMD)vs › | $29.47B | 17.30% | 16.00% | 15.15% | 14.03% |
| Biogen Inc. (BIIB)vs › | $29.55B | 4.65% | 5.11% | 6.74% | 8.29% |
| Mettler-Toledo International Inc. (MTD)vs › | $27.03B | 23.85% | 25.02% | 24.63% | 23.85% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.57B | 8.21% | 5.75% | 6.24% | 8.30% |
| Centene Corp. (CNC)vs › | $31.61B | -7.94% | -2.29% | 0.04% | 0.75% |
| Labcorp Holdings Inc. (LH)vs › | $24.70B | 4.93% | 4.41% | 4.42% | 6.18% |
| Zoetis Inc. (ZTS)vs › | $32.24B | 17.44% | 17.37% | 16.33% | 15.33% |
| Waters Corporation (WAT)vs › | $24.19B | 1.83% | 13.34% | 15.53% | 17.15% |
ROA
14.0%
ROE
31.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 13.19% |
| 2024-12-31 | 8.89% |
| 2023-12-31 | 8.64% |
| 2022-12-31 | 6.33% |
| 2021-12-31 | 4.40% |
| 2020-12-31 | 11.50% |
| 2019-12-31 | 4.22% |
| 2018-12-31 | -6.63% |
| 2017-12-31 | -5.55% |
| 2016-12-31 | -16.29% |
| 2015-12-31 | -19.73% |
| 2014-12-31 | -12.13% |
| 2013-12-31 | -24.33% |
| 2012-12-31 | -51.42% |
| 2011-12-31 | -37.14% |
| 2010-12-31 | -71.50% |
| 2009-12-31 | -114.01% |
| 2008-12-31 | -124.38% |
| 2007-12-31 | -59.38% |
| 2006-12-31 | -72.19% |
| 2005-12-31 | -54.24% |
| 2004-12-31 | -47.51% |
| 2003-12-31 | -47.74% |
| 2002-12-31 | 0.00% |
| 2001-12-31 | -72.60% |
| 2000-12-31 | -27.61% |
